Innovative medicine for everyone everywhere
Adocia is a clinical-stage biotechnology company specialized in the development of innovative treatments for diabetes and obesity.
Products
& platforms
Relying on disruptive technologies with strong intellectual property strategies, Adocia products and platforms range from innovative formulations of already-approved peptides and proteins to immunoprotective scaffold for cell therapies.
Adocia
presentation
Since its inception by the Soula family in 2005, Adocia has built a unique expertise in the field of diabetes and obesity. Adocia primary focus lies in developing innovative formulations of insulins and other metabolic hormones. With the ambition of becoming a leading player in hormonal treatments, Adocia has established a diverse pipeline of specialty products designed for the treatment of type 1 and type 2 diabetes as well as obesity.
Partnering
Adocia licenses-out its products and technologies after having established the proof-of-concept in human. Interested in partnering with us? Please reach out!
Media
